| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/06/2008 | US20080058307 Novel compounds as cannabinoid receptor ligands |
| 03/06/2008 | US20080058306 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitors(s) and treatments for vascular indications |
| 03/06/2008 | US20080058305 Processes for the purification of (3R,4S)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one |
| 03/06/2008 | US20080058304 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 03/06/2008 | US20080058303 Antiinflammatory agents |
| 03/06/2008 | US20080058302 Sulfamoyl Benzamides and Methods of Their Use |
| 03/06/2008 | US20080058301 Therapy for prostate cancer; administering androgen receptor |
| 03/06/2008 | US20080058300 use of compound 1436, an aminosterol tyrosine phosphatase (PTP1B) inhibitor also known as trodusquemine; obese patient also has type II diabetes, high serum cholesterol, sleep apnea, pickwickian syndrome and nonalcoholic steatohepatitis |
| 03/06/2008 | US20080058299 Method of treating or preventing bone deterioration or osteoporosis |
| 03/06/2008 | US20080058298 Blocking hedgehog protein transduction signal passageway using alkaloid steroid |
| 03/06/2008 | US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss |
| 03/06/2008 | US20080058296 Formulations and methods for treating rhinosinusitis |
| 03/06/2008 | US20080058295 Nasal pharmaceutical formulations and methods of using the same |
| 03/06/2008 | US20080058294 Glucocorticoid encapsulated within liposome; multiple sclerosis, anticancer agents |
| 03/06/2008 | US20080058293 Quinoline Derivates and Their Use in Therapy |
| 03/06/2008 | US20080058292 Administering synergistic mixture of adipocyte proteinG antagonist and peroxisome proliferator activator antagonist; concurrent administering niacin and non-steroid antiinflammatory drug |
| 03/06/2008 | US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders |
| 03/06/2008 | US20080058289 Using 2-(carbamimidoyl-methylamino)ethoxyphosphoric acid; oral administering; fine particle sizes |
| 03/06/2008 | US20080058288 Using 2-(carbamimidoyl -methyl-amino) ethoxy phosphoric acid in fine particle size |
| 03/06/2008 | US20080058287 Mesotherapy Cream |
| 03/06/2008 | US20080058286 Antidiabetic agents, metabolism disorders, cardiovascular disorders, antiinflammatory agents, fertility, muscular disorders, obesity; marine phosphatide |
| 03/06/2008 | US20080058285 Colored perfumed compositions comprising at least one alkyl-beta,beta'-diphenylacrylate or alkyl alpha-cyano-beta,beta'-diphenylacrylate compound and at least one soluble organic UV-A filter |
| 03/06/2008 | US20080058284 Pharmaceutical compositions of semicarbazones and/or thiosemicarbazones and/or their derivatives and products of these compositions and their uses as anticonvulsant, anti-nociceptive and anti-inflammatory agents, and in the angiogenic therapy |
| 03/06/2008 | US20080058283 Therapy for skin disorders |
| 03/06/2008 | US20080058282 Use of lactulose in the treatment of autism |
| 03/06/2008 | US20080058281 Skin Lightening Compositions Comprising Vitamines and Flavonoids |
| 03/06/2008 | US20080058280 Treatment of Lymphoma Using 10-Propargyl-10-Deazaaminopterin and Gemcitabine |
| 03/06/2008 | US20080058279 Such as 3-[4-(2-Octadec-9-enyloxycarbonyl-ethylamino)-butylamino]-propionic acid octadec-9-enyl ester dihydrochloride salt; use with vectors for in vivo transfection |
| 03/06/2008 | US20080058278 Reduce oxygen toxicity in lung diseases, dysplasia in premature infants; plasmid for coding sequence |
| 03/06/2008 | US20080058276 Cis, trans isomerization; serine, threonine profile; therapy, prevention neurodegenerative disorders |
| 03/06/2008 | US20080058275 Rna Interferases And Methods Of Use Thereof |
| 03/06/2008 | US20080058274 Mixture of active drugs in stable lipids; forming liposomes; doxorubicins encapsulated with ceramide |
| 03/06/2008 | US20080058273 Brain disorders; antitumor agents |
| 03/06/2008 | US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents |
| 03/06/2008 | US20080058264 Mixture of leucine and threonine |
| 03/06/2008 | US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators |
| 03/06/2008 | US20080058254 Composition and method for enhancing or promoting the activity of insulin, enhancing skeletal muscle growth, reducing skeletal muscle loss, and increasing the energy supply to skeletal muscle |
| 03/06/2008 | US20080058250 Using mixture of active drug and phosphate binder; active drugs include hypotensive agents, vitamin d, lipids, calcitrol, potassium salts,anemia therapy or alkalization agent |
| 03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057510 Human Vascular IBP-Like Growth Factor |
| 03/06/2008 | US20080057504 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
| 03/06/2008 | US20080057144 Time-release tablet containing thiamine, riboflavin, Niacin, vitamin B6, vitamin B12, eleuthero root, guarana root and L-Tyrosine, administered prior to falling asleep at night |
| 03/06/2008 | US20080057142 Compositions and methods for weight-loss and weight-loss maintenance in daytime and nighttime formulation |
| 03/06/2008 | US20080057140 Use of a Lignan for the Manufacture of a Composition for Preventing or Alleviating of Symptoms Relating to Estrogen Deficiency |
| 03/06/2008 | US20080057138 Restorative skin cream |
| 03/06/2008 | US20080057136 An ionogenic surfactant, a metal chelating complex with an affinity for protons, solvent and carrier; preferably cetylpyridinium chloride, EDTA-zinc complex, and isopropanol; fungicides for oral, topical or intravenous administration; dandruff, acne, dermatitis |
| 03/06/2008 | US20080057134 Antifungal compositions and method |
| 03/06/2008 | US20080057133 Preparation of Aqueous Clear Solution Dosage Forms with Bile Acids |
| 03/06/2008 | US20080057131 Glycolic acid-lactic acid copolymer matrix incorporated with a peptide drug and a corticosteroid; sustained release for two weeks; improved bioavailability |
| 03/06/2008 | US20080057129 Deposited by sublimation onto a carrier chosen from lactose, dextran, dextrose, and mannitol, and are suitable for administration by inhalation or injection; lung infections in patients with cystic fibrosis; calcitrol, azithromycin; improved bioavailability |
| 03/06/2008 | US20080057128 Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from |
| 03/06/2008 | US20080057126 Implant and process for its production |
| 03/06/2008 | US20080057125 Amorphous sodium salt of a benzimidazole PPI produced in situ, coated on hydroxypropyl methyl cellulose granulated and pelletized powder and covered with a sub-coating and an outer enteric coating; improved bioavailability and acidic stability, side effect reduction, lower dosages |
| 03/06/2008 | US20080057124 Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties |
| 03/06/2008 | US20080057123 Tablet core has the drug and an enteric material and is surrounded by one or more barrier layers of swellable, erodible, or gellable polymers; release rate increases in resopnse to increasing pH as the tablet descends the gastrointestinal tract; once daily dosing |
| 03/06/2008 | US20080057122 Acetaminophen pharmaceutical compositions |
| 03/06/2008 | US20080057119 low dosage of zolpidem, or zolpidem hemitartrate when formulated for delivery across the oral mucosa, can induce rapid onset of sleep without residual sedative effects upon awakening 2-4 hours late |
| 03/06/2008 | US20080057118 Divalproex pharmaceutical compositions |
| 03/06/2008 | US20080057117 Pharmaceutical composition made up of cannibus extracts |
| 03/06/2008 | US20080057115 2-propyloctanoic acid for treating neurodegenerative diseses contained in a capsule, internally taken safely without feeling acidness, pain, burning sensation in the oral cavity, dissoved quickly in stomach without delay; shell comprises gelatin, sacchride as base and glycerine as plasticizer, a fat |
| 03/06/2008 | US20080057113 virion vaccine anti-herpes simplex viruses containing hi-tech immunomodulator Polyoxidonium ( copolymer of 1,4-ethylene-piperazine N-oxide and (N-carboxyethyl)-1,4-ethylene-piperasinium bromide), valine, lysine together with metabolic amino acids; immunocompetent |
| 03/06/2008 | US20080057108 Functional food and method for preparation thereof |
| 03/06/2008 | US20080057107 Intravaginally administering mannose phosphate or salt and a carrier to increase viginal cell growth or cell maturation |
| 03/06/2008 | US20080057105 Medical devices having nanostructured coating for macromolecule delivery |
| 03/06/2008 | US20080057101 drug elution rate controlling matrix is disposed within the pores such that substantially none of the matrix protrudes from the pores and the porous body protects the matrix material of biocompatible, biodegradable natural or synthetic polymer; stents, endoprosptheses, catheters, dental implants |
| 03/06/2008 | US20080057098 Use of Bcl inhibitors For The Prevention Of Fibroproliferative Reclosure Of Dilated Blood Vessels And Other Iatrogenic Fibroproliferative Disorders |
| 03/06/2008 | US20080057096 Comprising stent body, first layer applied over stent body comprising a therapeutic substance and second layer applied over first layer comprising a fluoride-containing hydrophilic water insoluble crosslinked resin; biocompatible layer leaches fluoride to provide further therapy to patient |
| 03/06/2008 | US20080057091 Moisturizing, cosmetic, or anti-wrinkle composition comprising at least two hyaluronic acid fractions or salts thereof, wherein first fraction has molecular weight of 8,000-100,000 Da, and second fraction has molecular weight of 500,000-1,100,000 Da; may also have use in treating osteoarthritis, cancer |
| 03/06/2008 | US20080057088 Krebs cycle intermediate or precursor of Krebs cycle intermediate, pharmaceutically acceptable topical vehicle comprising a mitochondrial fuel or substance that is efficiently convertible to mitochondrial fuel by normal skin cell metabolism; for stimulating mitochondrial activity in skin cells |
| 03/06/2008 | US20080057086 Colon-targeted oral formulations of cytidine analogs |
| 03/06/2008 | US20080057083 Protecting an animal against a pathogen by administering protective agent which is able to stimulate the animal's immune system to produce a response which is protective against the pathogen, and an immunostimulant comprising a polycationic carbohydrate or derivative thereof; non-parenteral immunization |
| 03/06/2008 | US20080057080 Polynucleotide comprising a first nucleic acid fragment which encodes at least 20 contiguous amino acids of an influenza virus polypeptide, wherein codons of nucleic acid fragment are optimized for expression in humans; enhancing immune response of vertebrate in need of protection against IV infection |
| 03/06/2008 | US20080057076 Novel fibroblast growth factors |
| 03/06/2008 | US20080057074 Nitrogenous Heterocylic Derivative and Medicine Containing the Same as an Active Ingredient |
| 03/06/2008 | US20080057072 Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders |
| 03/06/2008 | US20080057071 Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057068 SARMS and method of use thereof |
| 03/06/2008 | US20080057066 Methods and compositions for targeting relt |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057062 Agent for Inducing senescence and apoptosis of cancer cell |
| 03/06/2008 | US20080057055 Human polynucleotide phosphorylase (hPNPaseold-35 or OLD-35); arthritis, atherosclerosis and Alzheimer's disease |
| 03/06/2008 | US20080057054 Controlling activity of telencephalin |
| 03/06/2008 | US20080057051 Method for fostering bone formation and preservation |
| 03/06/2008 | US20080057049 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 03/06/2008 | US20080057047 Antibiotic Associated Diarrhea (AAD),Clostridium difficile associated diarrhea (CDAD), Inflammatory Bowel Disease (IBD) |
| 03/06/2008 | US20080057036 comprising a Picornavirus capable of lytically infecting or killing a cell substantially in the absence of intercellular adhesion molecule |
| 03/06/2008 | US20080057035 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 03/06/2008 | US20080057031 Antiviral phosphinate compounds |
| 03/06/2008 | US20080057030 comprising administering an effective amount of Interferon-gamma (IFN-gamma) and corticosteroids; treatment of respiratory system disorders |
| 03/06/2008 | US20080057028 Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells |
| 03/06/2008 | US20080057026 Amphiphilic Star-Like Or Scorpion-Like Macromolecules, Various Compositions And Uses Threof |
| 03/06/2008 | US20080057025 Method for promoting bone formation |
| 03/06/2008 | US20080057024 drug/polymer conjugates/ suitable for introduction into blood vessels, using catheters |
| 03/06/2008 | US20080057023 comprising a solution of an aqueous ophthalmic agent such as artificial tears and oxygen |
| 03/06/2008 | US20080057022 sustained release mixture of polymers, drugs such as antiallergens, antiinflammatory agents or antiseptics, flow control agents and carriers, used for providing relief to discomfort of eyes |
| 03/06/2008 | US20080057021 Rinse-off personal care compositions comprising cationic perfume polumeric particles |
| 03/06/2008 | US20080057018 Compositions and methods of use thereof for the removal of ticks from epidermal tissue |